Clinical Trial Update: A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell) [Phase 3]

View source ↗

Summary

Phase III clinical trial update evaluating the long-term protective efficacy of a recombinant zoster vaccine produced in CHO cells; the study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Recombinant Zoster Vaccine (CHO Cell) (recombinant zoster vaccine (CHO cell))

Snippet

Sponsor: MAXVAX Biotechnology Limited Liability Company | Conditions: Herpes Zoster | Phase 3 | Status: ACTIVE_NOT_RECRUITING